Curevo, a Seattle-based biotech startup developing a vaccine against shingles, raised $110 million in a Series B round.

Moncef Slaoui, who ran the Operation Warp Speed Covid vaccine effort, is becoming chair of Curevo, a company developing a new ...

The shingles vaccine is recommended for healthy adults age 50 or older, and also for anyone age 19 years or older who has a ...

Curevo has set its sights on competing with GSK’s shingles vaccine dominance by securing $110m and securing a former ...

Amezosvatein has shown excellent immunogenicity and improved tolerability in Phase 2 study -- Medicxi leads round, joined by ...

Donna Kelce, mother of NFL stars Travis and Jason Kelce, highlights the painful condition of shingles, urging those over 50 ...

As adults age, the greater their chances of getting shingles. That is why health care experts recommend all adults 50 and older get vaccinated. "Oftentimes when somebody first starts developing ...

Even if you received childhood vaccinations it’s important to consult a doctor to determine whether you need a booster shot ...

The shingles vaccine isn’t just for preventing the rash—it may also help protect the heart and brain. According to research led by James Mbinta, the vaccine lowers the risk of heart attacks and ...

Patients who have a date of birth from September 2, 1943 and August 31, 1953 will have previously been called for vaccination ...

Shingles is linked to an elevated risk of stroke and heart attacks, with studies indicating that individuals with a history ...

Residents of the province between the ages of 65 and 70 years and immunocompromised residents over the age of 70 will be able ...